NESP 60ug

DRUG2 trials

Sponsors

HK inno.N Corporation, Yi Fang

Conditions

Healthy SubjectsRenal Anemia

Phase 1

Pharmacokinetics Study of CJ-40001 and NESP® After Single Dose Administration in Health Male Volunteers

CompletedNCT03542916

HK inno.N CorporationHealthy Subjects

Start: 2014-10-31End: 2015-12-31Updated: 2018-05-31

Phase 4

Pharmacokinetics Comparison Study of JT1801 and NESP® After Single Dose Administration in Chinese Health Male Volunteers

CompletedNCT05864261

Yi FangRenal Anemia

Start: 2023-05-15End: 2023-08-28Updated: 2023-11-22

Related Papers

Comparison of the Pharmacokinetic–Pharmacodynamic Relationships of Two Darbepoetin Alfa Formulations in Healthy Male Volunteers

BioDrugs2018-12-013 citations